spironolactone and semaglutide + Semaglutide: Safety, Interactions & Monitoring – PlexusDx Torsemide & Spironolactone Tablets 10/50

Description

December 18, 2024: FDA Updates Ozempic Warning Label to Include Pulmonary Aspiration as Adverse Reaction The FDA updated the warning label for Ozempic, the GLP-1 drug used to treat diabetes and lose weight

Monitor Health Metrics Regular Check-ups : Keep track of your weight, blood sugar levels, and other health metrics

That means we need to move beyond simplistic advice such as eat less and move more

Let your provider know about your stalled weight loss progress and ideas to overcome it

If you develop severe vomiting or dehydration while taking both medications, contact your healthcare provider promptly, as they may recommend temporarily pausing semaglutide until you recover